Detection of DFUs in clinical settings and telemedicine platforms is another game-changer. YOLO (You Only Look Once), Faster ...
Clinical Trials Arena on MSN1d
SolasCure initiates Phase II trial of chronic wound treatment gelUK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...
SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...
Calgary-based NanoTess makes a gel called NanoSALV that's designed to to help heal chronic wounds, skin injuries, infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback